Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name GENSIGHT BIOLOGICS S.A. Proposed Ticker GNST CUSIP N/A Business Description A clinical-stage biotechnology company discovering and developing novel therapies for mitochondrial and neurodegenerative diseases of the eye and, in the future, of the central nervous system. Lead Underwriter Canaccord Genuity Inc,Evercore Group L.L.C,Leerink Partners LLC Co-Managers N/A Initial Shares 47,00,000 Revised Initial Shares 4650000 Initial Price $13.00-$15.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.